Projects per year
- Gastroenterology - ADJUNCT CLINICAL ASSOCIATE PROFESSOR
A Phase 1 Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of Single and Multiple Doses of ABI-H2158 in Healthy Volunteers; and the Multiple-Ascending Dose Pharmacokinetics and Pharmacodynamics in Patients with Chronic Hepatitis B Infection.
Roberts, S. & Mitchell, J. L.
29/05/19 → 30/09/19
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of Durvalumab Monotherapy or in Combination with Bevacizumab as Adjuvant Therapy in Patients with Hepatocellular Carcinoma who are at High Risk of Recurrence After Curative Hepatic Resection or Ablation (EMERALD-2).
17/05/19 → 31/05/23
An Open-Label Study to Assess The Efficacy and Safety of LM011 In Subjects Diagnosed With Non-Alcoholic Steatohepatitis (NASH).
16/04/19 → 31/12/19
Research Output per year
Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levelsNicoll, A. J., Roberts, S. K., Lim, R., Mitchell, J., Weltman, M., George, J., Wigg, A., Stuart, K., Gow, P., MacQuillan, G., Tse, E., Levy, M., Sood, S., Zekry, A., Cheng, W., Mitchell, J., Skoien, R., Sievert, W., Strasser, S. I., McCaughan, G. W. & 1 others, 1 May 2019, In : Alimentary Pharmacology and Therapeutics. 49, 10, p. 1314-1322 9 p.
Research output: Contribution to journal › Article › Research › peer-review
Research output: Contribution to journal › Review Article › Research › peer-review
Letters: low FODMAP diet-directions for future research and the low FODMAP diet is not the only diet for IBS-authors' replyMitchell, H., Porter, J., Gibson, P. R., Barrett, J. & Garg, M., 1 Apr 2019, In : Alimentary Pharmacology and Therapeutics. 49, 8, p. 1109-1110 2 p.
Research output: Contribution to journal › Letter › Other › peer-review